AROW

Arrow is a ~$4.45B-asset upstate-NY community bank enjoying a sharp earnings recovery: FY2025 net income rose 47.9% to $44.0M and diluted EPS jumped 49.7% to $2.65, after two soft years (~$30M in 2023–2024). The engine is net interest margin — the MD&A shows tax-equivalent NIM expanding from 2.74% to 3.19% as interest expense fell ($83.3M → $77.0M) even while interest income grew, lifting net interest income to $133.2M. Efficiency improved markedly (efficiency ratio 67.68% → 61.97%) and return on average equity recovered to 10.66% from 7.72%. Asset quality looks pristine on the surface: nonperforming loans fell to 0.24% of loans with allowance coverage of a fortress-like 405.9%. The balance sheet is conservatively funded — long-term debt is negligible ($4.26M), Tier 1 leverage is 9.68%, and the company is returning capital via a rising dividend ($1.14/share, ~2.8% yield) and $10.2M of buybacks that shrank the share count.

The catch is that this earnings surge is largely a gift of the rate cycle, not structural growth. Assets grew only 3.2% and equity 7.7%; there is no revenue engine beyond spread income, and the MD&A itself flags that the FRB cut benchmark rates twice in 2024 and again in 2025. As rates fall, the deposit-cost relief that drove NIM from 2.74% to 3.19% can reverse, and a 45bp swing in a ~$4.2B earning-asset base is the whole story here. Beneath the headline asset-quality numbers, net charge-offs actually rose (0.09% → 0.19% of loans) and the provision built (0.16% → 0.21%), consistent with a bank still early in a credit-normalization cycle. The Risk Factors emphasize concentration in a single regional economy — Arrow is 'less able than larger regional competitors to spread the risk of unfavorable local economic conditions.'